Drug Trial Radar · NCT03304496
Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.
Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
1,400
Planned (sponsor's estimate)
Start
Mar 30, 2018
Primary completion
Mar 30, 2019
Study completion Mar 31, 2026
Sponsor
- Lead sponsor
- Instituto Nacional de Cardiologia Ignacio ChavezAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 9, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Femoral artery approach to perform coronary procedures is considered the standard technique for vascular access due to optimal catheter control, lower thromboembolic complications and immediate access due to the large diameter of the artery. Trans-radial approach has been shown to reduce major bleeding complications, vascular complications related to the site of puncture, including death from all causes, and to prevent post-procedure limb rest, greater comfort for patients, immediate ambulation, early discharge and reduction of costs. Previous studies have shown that intravenous, topical and intraarterial use of nitroglycerin produces vasodilation of the radial artery. Extravascular (subcutaneous) administration of nitroglycerin is extremely effective in restoring the radial pulse, and allows adequate cannulation.
Conditions
- Coronary Artery Disease
Interventions
Nitroglycerin 100 MCG/ML Injectable SolutionDrug
Previously described.
Saline SolutionDrug
Previously described.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Compound of crossover to femoral access and/or access site-related vascular complications.Time frame: Within 72 hours or at hospital discharge (whichever occurs first).
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Instituto Nacional de Cardiologia Ignacio Chavez
Mexico City, Tlalpan, Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.